CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder.
dc.rights.license | open | en_US |
dc.contributor.author | DE THONEL, Aurelie | |
dc.contributor.author | AHLSKOG, Johanna K | |
dc.contributor.author | DAUPIN, Kevin | |
dc.contributor.author | DUBREUIL, Veronique | |
dc.contributor.author | BERTHELET, Jeremy | |
dc.contributor.author | CHAPUT, Carole | |
dc.contributor.author | PIRES, Goeffrey | |
dc.contributor.author | LEONETTI, Camille | |
dc.contributor.author | ABANE, Ryma | |
dc.contributor.author | BARRIS, Lluis Cordon | |
dc.contributor.author | LERAY, Isabelle | |
dc.contributor.author | AALTO, Anna L | |
dc.contributor.author | NACERI, Sarah | |
dc.contributor.author | CORDONNIER, Marine | |
dc.contributor.author | BENASOLO, Carene | |
dc.contributor.author | SANIAL, Matthieu | |
dc.contributor.author | DUCHATEAU, Agathe | |
dc.contributor.author | VIHERVAARA, Anniina | |
dc.contributor.author | PUUSTINEN, Mikael C | |
dc.contributor.author | MIOZZO, Federico | |
hal.structure.identifier | Laboratoire Maladies Rares: Génétique et Métabolisme (Bordeaux) [U1211 INSERM/MRGM] | |
dc.contributor.author | FERGELOT, Patricia | |
dc.contributor.author | LEBIGOT, Elise | |
dc.contributor.author | VERLOES, Alain | |
dc.contributor.author | GRESSENS, Pierre | |
hal.structure.identifier | Laboratoire Maladies Rares: Génétique et Métabolisme (Bordeaux) [U1211 INSERM/MRGM] | |
dc.contributor.author | LACOMBE, Didier | |
dc.contributor.author | GOBBO, Jessica | |
dc.contributor.author | GARRIDO, Carmen | |
dc.contributor.author | WESTERHEIDE, Sandy D | |
dc.contributor.author | DAVID, Laurent | |
dc.contributor.author | PETITJEAN, Michel | |
dc.contributor.author | TABOUREAU, Olivier | |
dc.contributor.author | RODRIGUES-LIMA, Fernando | |
dc.contributor.author | PASSEMARD, Sandrine | |
dc.contributor.author | SABERAN-DJONEIDI, Delara | |
dc.contributor.author | NGUYEN, Laurent | |
dc.contributor.author | LANCASTER, Madeline | |
dc.contributor.author | SISTONEN, Lea | |
dc.contributor.author | MEZGER, Valerie | |
dc.date.accessioned | 2023-05-22T08:46:20Z | |
dc.date.available | 2023-05-22T08:46:20Z | |
dc.date.issued | 2022-11-16 | |
dc.identifier.issn | 2041-1723 | en_US |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/182215 | |
dc.description.abstractEn | Patients carrying autosomal dominant mutations in the histone/lysine acetyl transferases CBP or EP300 develop a neurodevelopmental disorder: Rubinstein-Taybi syndrome (RSTS). The biological pathways underlying these neurodevelopmental defects remain elusive. Here, we unravel the contribution of a stress-responsive pathway to RSTS. We characterize the structural and functional interaction between CBP/EP300 and heat-shock factor 2 (HSF2), a tuner of brain cortical development and major player in prenatal stress responses in the neocortex: CBP/EP300 acetylates HSF2, leading to the stabilization of the HSF2 protein. Consequently, RSTS patient-derived primary cells show decreased levels of HSF2 and HSF2-dependent alteration in their repertoire of molecular chaperones and stress response. Moreover, we unravel a CBP/EP300-HSF2-N-cadherin cascade that is also active in neurodevelopmental contexts, and show that its deregulation disturbs neuroepithelial integrity in 2D and 3D organoid models of cerebral development, generated from RSTS patient-derived iPSC cells, providing a molecular reading key for this complex pathology. | |
dc.language.iso | EN | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.title.en | CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder. | |
dc.title.alternative | Nat Commun | en_US |
dc.type | Article de revue | en_US |
dc.identifier.doi | 10.1038/s41467-022-34476-2 | en_US |
dc.identifier.pubmed | 36385105 | en_US |
bordeaux.journal | Nature Communications | en_US |
bordeaux.page | 7002 | en_US |
bordeaux.volume | 13 | en_US |
bordeaux.hal.laboratories | Maladies Rares : Génétique et Métabolisme (MRGM) - UMR 1211 | en_US |
bordeaux.issue | 1 | en_US |
bordeaux.institution | Université de Bordeaux | en_US |
bordeaux.institution | INSERM | en_US |
bordeaux.peerReviewed | oui | en_US |
bordeaux.inpress | non | en_US |
bordeaux.import.source | pubmed | |
hal.export | false | |
workflow.import.source | pubmed | |
dc.rights.cc | CC BY | en_US |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Nature%20Communications&rft.date=2022-11-16&rft.volume=13&rft.issue=1&rft.spage=7002&rft.epage=7002&rft.eissn=2041-1723&rft.issn=2041-1723&rft.au=DE%20THONEL,%20Aurelie&AHLSKOG,%20Johanna%20K&DAUPIN,%20Kevin&DUBREUIL,%20Veronique&BERTHELET,%20Jeremy&rft.genre=article |